Dear Friend, If you or someone you know is suffering from the symptoms of carpal tunnel syndrome, including numbness, tingling, pain and weakness in the hand(s), and may be interested in a free education and screening event, please continue reading. I am excited to tell you I have recently brought carpal tunnel release (CTR) using ultrasound guidance into my practice. Some of the reasons I selected CTR with ultrasound guidance for my practice include1-4 • Performed in a procedure room or oﬃce setting • Can be performed using local anesthesia • The small wrist incision is typically closed without sutures • Minimal pain medication – reduce or eliminate need for opioids • Postoperative therapy is typically not required, saving you time and money • Immediate motion in the hand for rapid recovery After the procedure, you’ll be able to resume activities as tolerated. Most patients can return to work and the activities they love within 3 to 6 days.1 If this is an option that you or someone you know would like to explore, please visit CureMyCarpalTunnel.com or contact Monadnock Orthopaedic Associates at (603) 924-2144. Best regards, Dr W. Bradley White, M.D. 1. Fowler JR, Chung KC, Miller LE. Multicenter pragmatic study of carpal tunnel release with ultrasound guidance. Expert Rev Med Devices. 2022 Mar;19(3):273-280. doi: 10.1080/17434440.2022.2048816. Epub 2022 Mar 10. PMID: 35236202. 2. Bergum RA, Ciota MR. Office-based carpal tunnel release using ultrasound guidance in a community setting: long-term results. Cureus. 2022 Jul 23;14(7):e27169. doi: 10.7759/cureus.27169. PMID: 35898805; PMCID: PMC9308387. 3. Rojo-Manaute JM, Capa-Grasa A, Chana-Rodriguez F, et al. Ultra-minimally invasive sonographically guided carpal tunnel release: a randomized clinical trial. J Ultrasound Med. 2016 Jun;35(6):1149-1157. 4. Henning PT, Yang L, Awan T, et al. Minimally invasive ultrasound-guided carpal tunnel release: preliminary clinical results. J Ultrasound Med. 2018 Nov;37(11):2699-2706. Refer to the device instructions for use for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. There are potential risks associated with UltraGuideCTR™. It may not be appropriate for all patients and not all patients may benefit. Talk to your doctor about the benefits and risks and whether carpal tunnel release with UltraGuideCTR is right for you. For more information about the risks, visit SonexHealth.com RX Only MP04142rA

WP_Post Object ( [ID] => 36589 [post_author] => 9192204 [post_date] => 2023-09-27 14:21:47 [post_date_gmt] => 2023-09-27 18:21:47 [post_content] => [post_title] => Dear Friend, If you or someone you know is suffering from the symptoms of carpal tunnel syndrome, including numbness, tingling, pain and weakness in the hand(s), and may be interested in a free education and screening event, please continue reading. I am excited to tell you I have recently brought carpal tunnel release (CTR) using ultrasound guidance into my practice. Some of the reasons I selected CTR with ultrasound guidance for my practice include1-4 • Performed in a procedure room or oﬃce setting • Can be performed using local anesthesia • The small wrist incision is typically closed without sutures • Minimal pain medication – reduce or eliminate need for opioids • Postoperative therapy is typically not required, saving you time and money • Immediate motion in the hand for rapid recovery After the procedure, you’ll be able to resume activities as tolerated. Most patients can return to work and the activities they love within 3 to 6 days.1 If this is an option that you or someone you know would like to explore, please visit CureMyCarpalTunnel.com or contact Monadnock Orthopaedic Associates at (603) 924-2144. Best regards, Dr W. Bradley White, M.D. 1. Fowler JR, Chung KC, Miller LE. Multicenter pragmatic study of carpal tunnel release with ultrasound guidance. Expert Rev Med Devices. 2022 Mar;19(3):273-280. doi: 10.1080/17434440.2022.2048816. Epub 2022 Mar 10. PMID: 35236202. 2. Bergum RA, Ciota MR. Office-based carpal tunnel release using ultrasound guidance in a community setting: long-term results. Cureus. 2022 Jul 23;14(7):e27169. doi: 10.7759/cureus.27169. PMID: 35898805; PMCID: PMC9308387. 3. Rojo-Manaute JM, Capa-Grasa A, Chana-Rodriguez F, et al. Ultra-minimally invasive sonographically guided carpal tunnel release: a randomized clinical trial. J Ultrasound Med. 2016 Jun;35(6):1149-1157. 4. Henning PT, Yang L, Awan T, et al. Minimally invasive ultrasound-guided carpal tunnel release: preliminary clinical results. J Ultrasound Med. 2018 Nov;37(11):2699-2706. Refer to the device instructions for use for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. There are potential risks associated with UltraGuideCTR™. It may not be appropriate for all patients and not all patients may benefit. Talk to your doctor about the benefits and risks and whether carpal tunnel release with UltraGuideCTR is right for you. For more information about the risks, visit SonexHealth.com RX Only MP04142rA [post_excerpt] => [post_status] => inherit [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => ctr_general-patient-letter-template_mp04142ra-edited [to_ping] => [pinged] => [post_modified] => 2023-09-27 14:22:51 [post_modified_gmt] => 2023-09-27 18:22:51 [post_content_filtered] => [post_parent] => 36584 [guid] => http://monadnockcommunityhospital.com/wp-content/uploads/2023/09/CTR_General-Patient-Letter-Template_MP04142rA-edited.png [menu_order] => 0 [post_type] => attachment [post_mime_type] => image/png [comment_count] => 0 [filter] => raw )

Array ( [_wp_attached_file] => Array ( [0] => 2023/09/CTR_General-Patient-Letter-Template_MP04142rA-edited.png ) [_wp_attachment_metadata] => Array ( [0] => a:6:{s:5:"width";i:5100;s:6:"height";i:6600;s:4:"file";s:64:"2023/09/CTR_General-Patient-Letter-Template_MP04142rA-edited.png";s:8:"filesize";i:1540805;s:5:"sizes";a:13:{s:6:"medium";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-278x360.png";s:5:"width";i:278;s:6:"height";i:360;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:55890;}s:5:"large";a:5:{s:4:"file";s:65:"CTR_General-Patient-Letter-Template_MP04142rA-edited-835x1080.png";s:5:"width";i:835;s:6:"height";i:1080;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:314843;}s:9:"thumbnail";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-270x270.png";s:5:"width";i:270;s:6:"height";i:270;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:48779;}s:12:"medium_large";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-768x994.png";s:5:"width";i:768;s:6:"height";i:994;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:280387;}s:9:"1536x1536";a:5:{s:4:"file";s:66:"CTR_General-Patient-Letter-Template_MP04142rA-edited-1187x1536.png";s:5:"width";i:1187;s:6:"height";i:1536;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:504154;}s:9:"2048x2048";a:5:{s:4:"file";s:66:"CTR_General-Patient-Letter-Template_MP04142rA-edited-1583x2048.png";s:5:"width";i:1583;s:6:"height";i:2048;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:716695;}s:10:"hero_large";a:5:{s:4:"file";s:65:"CTR_General-Patient-Letter-Template_MP04142rA-edited-1200x650.png";s:5:"width";i:1200;s:6:"height";i:650;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:210166;}s:11:"hero_medium";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-944x511.png";s:5:"width";i:944;s:6:"height";i:511;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:166202;}s:10:"hero_small";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-688x373.png";s:5:"width";i:688;s:6:"height";i:373;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:110339;}s:12:"square_large";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-688x688.png";s:5:"width";i:688;s:6:"height";i:688;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:189339;}s:13:"square_medium";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-540x540.png";s:5:"width";i:540;s:6:"height";i:540;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:132652;}s:12:"square_small";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-360x360.png";s:5:"width";i:360;s:6:"height";i:360;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:70491;}s:11:"square_tiny";a:5:{s:4:"file";s:64:"CTR_General-Patient-Letter-Template_MP04142rA-edited-180x180.png";s:5:"width";i:180;s:6:"height";i:180;s:9:"mime-type";s:9:"image/png";s:8:"filesize";i:20446;}}s:10:"image_meta";a:12:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";s:11:"orientation";s:1:"0";s:8:"keywords";a:0:{}}} ) )